Poly Medicure Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
Poly Medicure yıllık ortalama 23.2% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 17.6% annual. Gelirler growing yılda ortalama 17.4% oranında artmaktadır. Poly Medicure'in özkaynak karlılığı 11.4% ve net marjı 19.4%'dir.
Anahtar bilgiler
23.2%
Kazanç büyüme oranı
21.2%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 23.0% |
| Gelir büyüme oranı | 17.4% |
| Özkaynak getirisi | 11.4% |
| Net Marj | 19.4% |
| Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge
Nov 02
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Poly Medicure nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 24 | 15,225 | 2,949 | 2,844 | 189 |
| 30 Jun 24 | 14,397 | 2,696 | 2,590 | 188 |
| 31 Mar 24 | 13,758 | 2,583 | 2,516 | 190 |
| 31 Dec 23 | 13,046 | 2,487 | 2,349 | 198 |
| 30 Sep 23 | 12,498 | 2,337 | 2,278 | 193 |
| 30 Jun 23 | 11,872 | 2,150 | 2,151 | 182 |
| 31 Mar 23 | 11,152 | 1,793 | 2,076 | 178 |
| 31 Dec 22 | 10,659 | 1,566 | 1,979 | 171 |
| 30 Sep 22 | 10,113 | 1,411 | 1,866 | 178 |
| 30 Jun 22 | 9,600 | 1,359 | 1,751 | 188 |
| 31 Mar 22 | 9,231 | 1,465 | 1,671 | 188 |
| 31 Dec 21 | 8,785 | 1,492 | 1,590 | 174 |
| 30 Sep 21 | 8,518 | 1,500 | 1,544 | 159 |
| 30 Jun 21 | 8,280 | 1,468 | 1,489 | 140 |
| 31 Mar 21 | 7,865 | 1,359 | 1,448 | 131 |
| 31 Dec 20 | 7,448 | 1,197 | 1,434 | 129 |
| 30 Sep 20 | 7,218 | 1,094 | 1,409 | 124 |
| 30 Jun 20 | 6,960 | 1,028 | 1,359 | 121 |
| 31 Mar 20 | 6,872 | 959 | 1,431 | 119 |
| 31 Dec 19 | 6,881 | 947 | 1,427 | 97 |
| 30 Sep 19 | 6,625 | 858 | 1,377 | 98 |
| 30 Jun 19 | 6,388 | 719 | 1,229 | 100 |
| 31 Mar 19 | 6,108 | 654 | 1,224 | 101 |
| 31 Mar 18 | 5,204 | 706 | 1,035 | 100 |
| 31 Mar 17 | 4,550 | 551 | 931 | 90 |
| 31 Mar 16 | 4,123 | 483 | 791 | 87 |
| 31 Mar 15 | 3,903 | 623 | 687 | 85 |
| 31 Mar 14 | 3,222 | 451 | 784 | 59 |
Kaliteli Kazançlar: POLYMED yüksek düzeyde nakit dışı kazança sahiptir.
Büyüyen Kar Marjı: POLYMED 'nin mevcut net kar marjları (19.4%) geçen yılın (18.7%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: POLYMED şirketinin kazançları son 5 yılda yılda 23.2% oranında önemli ölçüde arttı.
Büyüme Hızlandırma: POLYMED 'un son bir yıldaki kazanç büyümesi ( 26.2% ) 5 yıllık ortalamasını (yıllık 23.2% ) aşıyor.
Kazançlar vs. Sektör: POLYMED geçen yılki kazanç büyümesi ( 26.2% ) Medical Equipment sektörünün 8.8% değerini aştı.
Özkaynak Getirisi
Yüksek ROE: POLYMED 'nin Özsermaye Getirisi ( 11.4% ) düşük olarak değerlendiriliyor.